Literature DB >> 11085842

The incidence of fracture among patients with inflammatory bowel disease. A population-based cohort study.

C N Bernstein1, J F Blanchard, W Leslie, A Wajda, B N Yu.   

Abstract

BACKGROUND: The clinical significance of the high prevalence of osteopenia in inflammatory bowel disease is unclear.
OBJECTIVE: To determine whether persons with inflammatory bowel disease have increased incidence of fracture.
DESIGN: Population-based matched cohort study.
SETTING: Manitoba, Canada. PATIENTS: Patients with inflammatory bowel disease in the University of Manitoba IBD Database (n = 6027) were matched to 10 randomly selected persons in the general population without inflammatory bowel disease (n = 60 270) by year, age, sex, and postal area of residence. MEASUREMENTS: The incidence of hospitalization for hip fracture was determined on the basis of hospital discharge abstracts. Outpatient medical billing records and hospital discharge abstracts were used to calculate the incidence of spine, rib, and forearm fractures. Rates were calculated on the basis of person-years of follow-up for 1984 to 1997.
RESULTS: Persons with inflammatory bowel disease had significantly increased incidence of fractures at the spine (incidence rate ratio [IRR], 1.74 [95% CI, 1.34 to 2.24]; P < 0.001), hip (IRR, 1.59 [CI, 1.27 to 2.00]; P < 0.001), wrist/forearm (IRR, 1.33 [CI, 1.11 to 1.58]; P = 0.001), and rib (IRR, 1.25 [CI, 1.02 to 1.52]; P = 0.03) and of any of these fractures (IRR, 1.41 [CI, 1.27 to 1.56]; P < 0.001).
CONCLUSION: The incidence of fracture among persons with inflammatory bowel disease is 40% greater than that in the general population.

Entities:  

Mesh:

Year:  2000        PMID: 11085842     DOI: 10.7326/0003-4819-133-10-200011210-00012

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  114 in total

1.  Osteoporosis in patients with inflammatory bowel disease.

Authors:  N K Arden; C Cooper
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

2.  Osteoporosis in inflammatory bowel disease.

Authors:  J Compston
Journal:  Gut       Date:  2003-01       Impact factor: 23.059

Review 3.  Management of Ulcerative Colitis in the Elderly.

Authors:  Manish P Shrestha; Sasha Taleban
Journal:  Drugs Aging       Date:  2019-01       Impact factor: 3.923

4.  Childhood onset arthritis is associated with an increased risk of fracture: a population based study using the General Practice Research Database.

Authors:  J M Burnham; J Shults; R Weinstein; J D Lewis; M B Leonard
Journal:  Ann Rheum Dis       Date:  2006-04-20       Impact factor: 19.103

5.  Osteoporosis and gastrointestinal disease.

Authors:  Seymour Katz; Stuart Weinerman
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-08

6.  Measurement of vitamin D levels in inflammatory bowel disease patients reveals a subset of Crohn's disease patients with elevated 1,25-dihydroxyvitamin D and low bone mineral density.

Authors:  M T Abreu; V Kantorovich; E A Vasiliauskas; U Gruntmanis; R Matuk; K Daigle; S Chen; D Zehnder; Y-C Lin; H Yang; M Hewison; J S Adams
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

7.  Bone mineral density, vitamin D, and disease activity in children newly diagnosed with inflammatory bowel disease.

Authors:  Wael El-Matary; Sheena Sikora; Donald Spady
Journal:  Dig Dis Sci       Date:  2010-08-20       Impact factor: 3.199

Review 8.  The global burden of IBD: from 2015 to 2025.

Authors:  Gilaad G Kaplan
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-09-01       Impact factor: 46.802

9.  Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's Disease.

Authors:  Lindsay M Griffin; Meena Thayu; Robert N Baldassano; Mark D DeBoer; Babette S Zemel; Michelle R Denburg; Lee A Denson; Justine Shults; Rita Herskovitz; Jin Long; Mary B Leonard
Journal:  J Clin Endocrinol Metab       Date:  2015-04-28       Impact factor: 5.958

Review 10.  Perspectives on osteoporosis in pediatric inflammatory bowel disease.

Authors:  Manisha Harpavat; David J Keljo
Journal:  Curr Gastroenterol Rep       Date:  2003-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.